The Association Between PIV and Mortality in US Stroke Survivors: A NHANES 1999–2018 Retrospective Cohort Study
Health Science Reports · 2026-07 · 9 (7)
DOI: 10.1002/hsr2.72801 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Health Science Reports, online erschienen am 14.07.2026. Verfasst von Ying Lyu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Psychiatry, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital Capital Medical University Beijing Chin…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background and Aims Stroke is a leading cause of mortality and disability worldwide. The pan‐immune‐inflammation value (PIV) has emerged as a composite marker of systemic immune‐inflammatory status. We aimed to investigate the association of PIV with mortality in US adults with a history of stroke.
Methods
We analyzed 1948 participants in the 1999–2018 National Health and Nutrition Examination Survey (NHANES). Baseline PIV was calculated from routine blood counts as (neutrophils × platelets × monocytes ÷ lymphocytes). Mortality outcomes were ascertained through linked death records. A generalized additive model incorporating restricted cubic splines was employed to characterize the dose–response relationship between PIV and mortality risk. When statistically significant nonlinearity was detected in the exposure–outcome association, a two‐piecewise Cox proportional hazards model was applied to estimate hazard ratios for each segment.
Results
Among 1948 participants, 904 deaths (46.4%) occurred over a median follow‐up of 75 months; the mean age was 66.8 ± 13.3 years. PIV exhibited a statistically significant J‐shaped association with all‐cause mortality ( p = 0.001), with an inflection point ≈ 133.8. Below this threshold, each 100‐unit increase in PIV was associated with a 53% reduction in mortality hazard (HR: 0.47; 95% confidence interval (CI): 0.30–0.75; p < 0.01). Above it, each 100‐unit increase corresponded to a 9% increase in mortality hazard (HR: 1.09; 95% CI: 1.05–1.12; p < 0.001). In categorical analyses, using PIV 180–220 as the reference range, participants with PIV > 220 had a significantly higher risk of all‐cause mortality (HR: 1.47; 95% CI: 1.14–1.89; p = 0.002).
Conclusion
Among US stroke survivors, both abnormally low and high PIV levels were associated with an increased risk of mortality in a J‐shaped pattern. As a composite index derived from routine blood counts, PIV may serve as an accessible candidate indicator for risk assessment in stroke survivors, though prospective studies are needed to validate these findings and elucidate the underlying mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Psychiatry, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital Capital Medical University Beijing China.
ORCID-Profile: Ying Lyu
Zitieren
APA
Lyu, Y., Yin, Y., & Ma, J. (2026). The Association Between PIV and Mortality in US Stroke Survivors: A NHANES 1999–2018 Retrospective Cohort Study. Health Science Reports, 9(7). https://doi.org/10.1002/hsr2.72801
Vancouver
Lyu Y, Yin Y, Ma J. The Association Between PIV and Mortality in US Stroke Survivors: A NHANES 1999–2018 Retrospective Cohort Study. Health Science Reports. 2026;9(7). doi:10.1002/hsr2.72801
BibTeX
@article{Lyu2026,
author = {Lyu, Ying and Yin, Yuhui and Ma, Junfang},
title = {The Association Between PIV and Mortality in US Stroke Survivors: A NHANES 1999–2018 Retrospective Cohort Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {7},
doi = {10.1002/hsr2.72801}
}
EUVIMED